Related Experiment Video
Updated: Nov 25, 2025

05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
10.0K
Wrangling Shape-Shifting Morpheeins to Tackle Disease and Approach Drug Discovery
1Fox Chase Cancer Center, Philadelphia, PA, United States.
Frontiers in Molecular Biosciences
|December 17, 2020
Summary
Morpheins are proteins that change shape and reassemble, offering new ways to understand diseases and develop allosteric therapeutics. This dynamic protein behavior is key for drug design and metabolic research.
Area of Science:
- Biochemistry
- Structural Biology
- Drug Discovery
Background:
- Proteins can exist as dynamic entities, capable of disassembly and reassembly into different functional forms, termed morpheeins or transformers.
- This protein plasticity represents a largely unexplored area with significant implications for biological processes and disease mechanisms.
Purpose of the Study:
- To explore the concept of morpheeins within the framework of protein structure dynamics.
- To illustrate the relevance of morpheeins using an example of an inborn error of metabolism and potential herbicide development.
- To outline the application of morpheeins in understanding diseases and designing novel therapeutics.
Main Methods:
- Conceptual review of protein structure dynamics.
- Case study analysis of a specific metabolic disorder.
- Exploration of allosteric modulation principles.
Main Results:
- Morpheens offer a novel paradigm for understanding protein function and dysfunction.
- The dynamic nature of morpheeins has implications for both human metabolic diseases and agricultural applications (e.g., herbicides).
Conclusions:
- Understanding morpheeins opens new avenues for therapeutic intervention and drug design.
- The dynamic assembly of proteins provides a rich context for developing targeted allosteric therapeutics and bioactive molecules.
Related Concept Videos
Drug Discovery: Overview
10.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.5K
Structure-Activity Relationships and Drug Design
1.4K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.4K
Principles of Drug Action
7.6K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
7.6K
Drug Administration and Therapy Phases: Overview
984
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
984
Targets for Drug Action: Overview
9.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.1K
Drug Biotransformation: Overview
3.3K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
3.3K

